Survival analysis by UALCAN database revealed that low expression of GUCA2A was significantly associated with lower survival rates of colon adenocarcinoma patients (Fig. 8A) and low expression of GUCA2A is not significantly correlated with rectal adenocarcinoma’s poor prognosis (Fig. 8B). Here, GUCA2A is linked to colon adenocarcinoma.